Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
Part of paid clinical trials in Norfolk, Virginia.
- Sponsor
- Endoron Medical
- Study ID
- NCT06586021
- Status
- Recruiting
Conditions
- Abdominal Aortic Aneurysm (AAA)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Aortoseal Endostapling System — DEVICEAortoseal Endostapling System
Study Details
The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.
Key Dates
- Start date
- Feb 6, 2024
- Status verified
- Mar 2025
- Primary completion
- Sep 1, 2029
- Completion
- Nov 1, 2029
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Aortoseal Endostapling SystemProspective, early feasibility, non-randomized, single arm, multi-center, open-label clinical study
Primary Outcome Measure
Rate of Major Adverse Events [ Time Frame: through 5 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sentara Health Research Center | Norfolk | Virginia | 23507 | Principal Investigator (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Norfolk, VA
By research site